The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

Key PointsChikungunya virus (CHIKV) is a mosquito-borne RNA virus first identified in Tanzania in the 1950s.Chikungunya is generally characterized by ...

RNA vaccine technology has emerged as a groundbreaking approach in the field of immunology and infectious disease prevention.

The United States may be heading into its second severe flu season in a row, driven by a mutated strain called subclade K ...

In this article, ReiThera's scientific and operational leaders discuss ReiThera’s proprietary platforms, process development ...

Apriori Bio, a Flagship Pioneering portfolio company, and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) have announced a research collaboration to co-develop ...

A new study shows that the effectiveness of current vaccines against porcine reproductive and respiratory syndrome virus (PRRSV) is due to the response of T cells against the disease, rather than the ...

Pfizer’s respiratory syncytial virus vaccine was more than 90% effective among older adults during the first season it was available, including among those with underlying conditions or severe disease ...

Raccoon Rabies Control Program uses baited vaccine blocks to prevent rabies spread among raccoons, feral cats and other ...

Ethiopia is experiencing its first recorded outbreak of the deadly Marburg virus, unfolding amid political unrest, ...

The training brought together journalists, scientists, and health communicators to deepen their understanding of vaccines, ...